(Q46954005)

English

Effect of the ABCB1 modulators elacridar and tariquidar on the distribution of paclitaxel in nude mice

scientific article published on 12 October 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17932689

Effect of the ABCB1 modulators elacridar and tariquidar on the distribution of paclitaxel in nude mice (English)

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17932689

1 reference

based on heuristic

inferred from title

author name string

Martina Hubensack

1

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17932689

Christine Müller

2

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17932689

Peter Höcherl

3

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17932689

Stephan Fellner

4

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17932689

Thilo Spruss

5

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17932689

Günther Bernhardt

6

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17932689

Armin Buschauer

7

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17932689

publication date

12 October 2007

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17932689

Journal of Cancer Research and Clinical Oncology

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17932689

134

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17932689

597-607

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17932689

5

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17932689

https://scigraph.springernature.com/pub.10.1007/s00432-007-0323-9

0 references

Transport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS00432-007-0323-9

21 January 2018

Vincristine-resistant human cancer KB cell line and increased expression of multidrug-resistance gene

1 reference

https://api.crossref.org/works/10.1007%2FS00432-007-0323-9

21 January 2018

Enhanced oral bioavailability of paclitaxel in mice treated with the P-glycoprotein blocker SDZ PSC 833.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-007-0323-9

21 January 2018

Targeting multidrug resistance in cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial of XR9576 in healthy volunteers demonstrates modulation of P-glycoprotein in CD56+ lymphocytes after oral and intravenous administration.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical pharmacokinetics of doxorubicin in combination with GF120918, a potent inhibitor of MDR1 P-glycoprotein

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Standardized kinetic microassay to quantify differential chemosensitivity on the basis of proliferative activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activity of novel dual action MDR anthranilamide modulators with inhibitory activity on CYP-450 (Part 2).

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased penetration of paclitaxel into the brain by inhibition of P-Glycoprotein.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of P-glycoprotein and BCRP inhibitors to improve oral bioavailability and CNS penetration of anticancer drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modulation of drug transporters at the blood-brain barrier

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of GF120918, a potent P-glycoprotein inhibitor, on morphine pharmacokinetics and pharmacodynamics in the rat

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overcoming Multidrug Resistance in Cancer: An Update on the Clinical Strategy of Inhibiting P-Glycoprotein

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased oral bioavailability of topotecan in combination with the breast cancer resistance protein and P-glycoprotein inhibitor GF120918.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of paclitaxel in the treatment of primary and metastatic brain tumors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reversal of P-glycoprotein mediated multidrug resistance by novel anthranilamide derivatives

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The erythromycin breath test reflects P-glycoprotein function independently of cytochrome P450 3A activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determination of paclitaxel and metabolites in mouse plasma, tissues, urine and faeces by semi-automated reversed-phase high-performance liquid chromatography

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synthesis and activity against multidrug resistance in Chinese hamster ovary cells of new acridone-4-carboxamides

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessing safety and efficacy of directed P-glycoprotein inhibition to improve the pharmacokinetic properties of saquinavir coadministered with ritonavir

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved penetration of docetaxel into the brain by co-administration of inhibitors of P-glycoprotein

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug resistance in brain diseases and the role of drug efflux transporters.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

GF120918, a P-glycoprotein modulator, increases the concentration of unbound amprenavir in the central nervous system in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of in vitro P-glycoprotein screening assays: recommendations for their use in drug discovery

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug delivery to brain via the blood-brain barrier

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibitors of kinesin Eg5: antiproliferative activity of monastrol analogues against human glioblastoma cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preclinical pharmacokinetic properties of the P-glycoprotein inhibitor GF120918A (HCl salt of GF120918, 9,10-dihydro-5-methoxy-9-oxo-N-[4-[2-(1,2,3,4-tetrahydro-6,7-dimethoxy-2-isoquinolinyl)ethyl]phenyl]-4-acridine-carboxamide) in the mouse, rat, d

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Importance of P-glycoprotein at blood-tissue barriers

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modulation of p-glycoprotein transport function at the blood-brain barrier

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

P-glycoprotein and cytochrome P-450 3A inhibition: dissociation of inhibitory potencies

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The multidrug resistance modulator valspodar (PSC 833) is metabolized by human cytochrome P450 3A. Implications for drug-drug interactions and pharmacological activity of the main metabolite.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New drugs in recurrent high grade gliomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluorescent cellular indicators are extruded by the multidrug resistance protein.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00432-007-0323-9

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17932689

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17932689

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46954005&oldid=2139506033"